Who Paid My Doc
Tecentriq Oncology Extension Study
Research payments
$6,896,786
Through program year 2025, $6,896,786 in research payments was reported against Tecentriq Oncology Extension Study, across 1,383 payments, paid by Genentech, Inc..
- Paid by
- Genentech, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $107,296 | 11 |
| 2024 | Research | $315,496 | 248 |
| 2023 | Research | $707,017 | 136 |
| 2022 | Research | $1,003,585 | 198 |
| 2021 | Research | $1,424,819 | 302 |
| 2020 | Research | $1,518,042 | 233 |
| 2019 | Research | $1,820,530 | 255 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Michael Shafique Tampa, FL Named on 64 payments
- Timothy Larson Sacramento, CA Named on 59 payments
- Christopher Yasenchak Eugene, OR Named on 59 payments
- Charles Cowey Dallas, TX Named on 44 payments
- Mohit Narang Columbia, MD Named on 29 payments
- John Powderly Huntersville, NC Named on 28 payments
- Nicholas Vogelzang Las Vegas, NV Named on 28 payments
- Allen Cohn Englewood, CO Named on 25 payments
- Howard Burris Nashville, TN Named on 25 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.